- Home
- ANEB vs LGL Comparison
ANEB vs LGL Comparison
Compare ANEB & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- LGL
- Stock Information
- Founded
- ANEB 2020
- LGL 1917
- Country
- ANEB United States
- LGL United States
- Employees
- ANEB N/A
- LGL N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- LGL Industrial Machinery/Components
- Sector
- ANEB Health Care
- LGL Technology
- Exchange
- ANEB Nasdaq
- LGL Nasdaq
- Market Cap
- ANEB 111.8M
- LGL 34.1M
- IPO Year
- ANEB 2021
- LGL N/A
- Fundamental
- Price
- ANEB $2.74
- LGL $6.25
- Analyst Decision
- ANEB Buy
- LGL
- Analyst Count
- ANEB 2
- LGL 0
- Target Price
- ANEB $8.00
- LGL N/A
- AVG Volume (30 Days)
- ANEB 29.2K
- LGL 5.0K
- Earning Date
- ANEB 11-12-2025
- LGL 11-12-2025
- Dividend Yield
- ANEB N/A
- LGL N/A
- EPS Growth
- ANEB N/A
- LGL N/A
- EPS
- ANEB N/A
- LGL 0.04
- Revenue
- ANEB N/A
- LGL $4,178,000.00
- Revenue This Year
- ANEB N/A
- LGL N/A
- Revenue Next Year
- ANEB N/A
- LGL N/A
- P/E Ratio
- ANEB N/A
- LGL $152.97
- Revenue Growth
- ANEB N/A
- LGL 6.34
- 52 Week Low
- ANEB $0.80
- LGL $5.60
- 52 Week High
- ANEB $3.42
- LGL $9.74
- Technical
- Relative Strength Index (RSI)
- ANEB 64.77
- LGL 41.98
- Support Level
- ANEB $2.50
- LGL $6.15
- Resistance Level
- ANEB $2.85
- LGL $6.45
- Average True Range (ATR)
- ANEB 0.15
- LGL 0.19
- MACD
- ANEB 0.04
- LGL -0.02
- Stochastic Oscillator
- ANEB 87.09
- LGL 15.38
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.